Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines

Información del proyecto

PHA-ST-TRAIN-VAC

Identificador del acuerdo de subvención: 675370

DOI

10.3030/675370

Proyecto cerrado

Fecha de la firma de la CE 30 Junio 2016

Fecha de inicio 1 Junio 2016

Fecha de finalización 31 Mayo 2020

Financiado con arreglo a

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coste total

€ 1 062 698,40

Aportación de la UE

€ 1 062 698,40

Coordinado por

UNIVERSITY OF STRATHCLYDE
United Kingdom

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (26)

Identification of Rabies antigen for alternative vaccination routes

Identification of RSV antigen for alternative vaccination routes

Immunological properties of the modified GBS antigen
Bio-distribution of lipid nanoparticles
Identification of self-amplifying Rabies RNA construct

Identification of self-amplifying RSV RNA construct

Optimised adjuvant system for GBS antigen presentation
Optimised adjuvant system for a Rabies vaccine

Optimised adjuvant system for an RSV vaccine

Model to investigate intracellular ROS, antigen presentation and specific T cell responses
Evaluating polymeric particles, cationic emulsions and lipoplex formulations
Bio-distribution of adjuvants and associated antigens–mucosal routes
Metabolic factors that contribute to the impaired adaptive immunity in older adults
Key physico-chemical attributes of alum, emulsion, liposome and nanoparticle systems shown to be effective as adjuvants
Bio-distribution of adjuvants and their associated antigen - 1
Comparing the immune response efficacy of antigen and adjuvant combinations - mucosal routes
Optimised adjuvant attributes for self-amplifying RNA vaccines
Bio-distribution of selected polymeric particles, cationic emulsions and lipoplexes
Evaluation of the immune response efficacy
Comparison of cellular uptake in monocyte-derived macrophages and dendritic cells
Structural flexibility of the MenB Antigen

Structural flexibility of the GBS Antigen

Impact of adjuvant design
Identification of T-cell epitopes
Modulation of T-cell epitope affinity
Key biophysical and physico-chemical attributes of current lipid nanoparticles
Bio-distribution of adjuvants and their associated antigen - 2
Adjuvant properties identified
Correlation of adjuvant properties (identified in WP2) with efficacy of immunisation
Interactions of GBS and Rabies antigen and adjuvants

Interactions of GBS and RSV antigen and adjuvants

Other (5)

4 ESRs with the skills to influence, cause an effect, and lead on policy development and economic prosperity in their research field
4 ESRs with the skills and methods to ensure they can enthusiastically convey their science and reach all audiences
Deliver Outreach events at the British Science Festival and using on-line media
4 ESRs trained to PhD level
ESRs who will make a quantifiable difference with their research through engagement with a full range of stakeholders and external partners

Open Research Data Pilot (1)

Data management plan

Agreement and implementation of a data management plan.

Publicaciones

Peer reviewed articles (9)

Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection

Autores: Gustavo Lou, Giulia Anderluzzi, Signe Tandrup Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell Johnson, Craig W. Roberts, Derek T. O'Hagan, Barbara C. Baudner, Yvonne Perrie
Publicado en: Journal of Controlled Release, Edición Online ahead of print., 2020, Página(s) Online ahead of print., ISSN 0168-3659
Editor: Elsevier BV
DOI: 10.1016/j.jconrel.2020.06.027

Scalable Manufacturing Processes for Solid Lipid Nanoparticles

Autores: Giulia Anderluzzi, Gustavo Lou, Yang Su, Yvonne Perrie
Publicado en: Pharmaceutical Nanotechnology, Edición 7/6, 2019, Página(s) 444-459, ISSN 2211-7385
Editor: Bentham Science
DOI: 10.2174/2211738507666190925112942

Microfluidic Manufacture of Solid Lipid Nanoparticles: A Case Study on Tristearin-Based Systems.

Autores: Giulia Anderluzzi, Yvonne Perrie
Publicado en: Drug Delivery Letters, Edición 09, 2019, ISSN 2210-3031
Editor: Bentham Science
DOI: 10.2174/2210303109666190807104437

A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations

Autores: Gustavo Lou, Giulia Anderluzzi, Stuart Woods, Craig W. Roberts, Yvonne Perrie
Publicado en: European Journal of Pharmaceutics and Biopharmaceutics, Edición 143, 2019, Página(s) 51-60, ISSN 0939-6411
Editor: Elsevier BV
DOI: 10.1016/j.ejpb.2019.08.013

Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines

Autores: Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie
Publicado en: Vaccines, Edición 8/2, 2020, Página(s) 212, ISSN 2076-393X
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines8020212

Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes

Autores: Cameron Webb, Neil Forbes, Carla B. Roces, Giulia Anderluzzi, Gustavo Lou, Suraj Abraham, Logan Ingalls, Keara Marshall, Timothy J. Leaver, Julie A. Watts, Jonathan W. Aylott, Yvonne Perrie
Publicado en: International Journal of Pharmaceutics, Edición 582, 2020, Página(s) 119266, ISSN 0378-5173
Editor: Elsevier BV
DOI: 10.1016/j.ijpharm.2020.119266

Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines

Autores: Roshan Goswami, Despo Chatzikleanthous, Gustavo Lou, Fabiola Giusti, Alessandra Bonci, Marianna Taccone, Michela Brazzoli, Simona Gallorini, Ilaria Ferlenghi, Francesco Berti, Derek T. O’Hagan, Carlo Pergola, Barbara C. Baudner, Roberto Adamo
Publicado en: ACS Infectious Diseases, Edición 5/9, 2019, Página(s) 1546-1558, ISSN 2373-8227
Editor: ACS
DOI: 10.1021/acsinfecdis.9b00084

Synthesis of protein conjugates adsorbed on cationic liposomes surface

Autores: Despo Chatzikleanthous, Robert Cunliffe, Filippo Carboni, Maria Rosaria Romano, Derek T. O'Hagan, Craig W. Roberts, Yvonne Perrie, Roberto Adamo
Publicado en: MethodsX, Edición 7, 2020, Página(s) 100942, ISSN 2215-0161
Editor: ELSEVIER
DOI: 10.1016/j.mex.2020.100942

Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes

Autores: Despo Chatzikleanthous, Signe Tandrup Schmidt, Giada Buffi, Ida Paciello, Robert Cunliffe, Filippo Carboni, Maria Rosaria Romano, Derek T. O'Hagan, Ugo D'Oro, Stuart Woods, Craig W. Roberts, Yvonne Perrie, Roberto Adamo
Publicado en: Journal of Controlled Release, Edición 323, 2020, Página(s) 125-137, ISSN 0168-3659
Editor: Elsevier BV
DOI: 10.1016/j.jconrel.2020.04.001